Dual-time points 18F-FDG PET/CT imaging in detection of bone metastases from hepatocellular carcinoma

International Journal of Clinical and Experimental Medicine

Volumn 6, Issue 2, 2013, Pages 144-148

  Zhao, Xueren ^a   Yi, Alex ^a   Ariza, George ^a   Salcido, Lee ^a  

^a Loma Linda VA Hospital   (United States)

Author keywords

18F FDG PET CT; Bone metastases; Bone scan; Dual time points imaging; Hepatocellular carcinoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; HYDROXYMETHYLENE DIPHOSPHATE TC 99M; MEMBRANE PROTEIN; PROTEIN HEPPAR1; RADIOPHARMACEUTICAL AGENT; SORAFENIB; UNCLASSIFIED DRUG;

ADULT; ARM PAIN; ARTICLE; BONE BIOPSY; BONE METASTASIS; BONE RADIOGRAPHY; BONE SCINTISCANNING; CANCER STAGING; CASE REPORT; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; GLUCOSE BLOOD LEVEL; HUMAN; HUMERUS FRACTURE; IMAGE ANALYSIS; LIVER CELL CARCINOMA; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; RADIATION EXPOSURE; TUMOR DIFFERENTIATION; WHOLE BODY SCINTISCANNING;

EID: 84873135189     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970-2002. JAMA 2005; 294: 1255-1259.
2. Bosch FX, Ribes J, Diaz M, Cléries R. Primary liver cancer: Worldwide incidence and trends. Gastroenterology 2004; 127: S5-S16.
3. Perz JF, Armstrong GL, Farrington LA, Far-rington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006; 45: 529-538.
4. Chu CM, Liaw YF. Hepatitis B virus-related cirrhosis: Natural history and treatment. Semin Liver Dis 2006; 26: 142-152.
5. Kitamura T, Ichikawa T, Erturk SM, Nakajima H, Sou H, Araki T, Okada S, Enomoto N. Detection of hypervascular hepatocellular carcinoma with multidetector-row CT: Single arterial-phase imaging with computer-assisted automatic bolus-tracking technique compared with double arterial-phase imaging. J Comput Assist Tomogr 2008; 32: 724-729.
6. Kim MJ, Choi JY, Chung YE, Choi SY. Magnetic resonance imaging of hepatocellular carcinoma using contrast media. Oncology 2008; 75 sppl 1: 72-82.
7. Sugiyama M, Sakahara H, Torizuka T, Kanno T, Nakamura F, Futatsubashi M, Nakamura S. 18F FDG PET in detection of extrahepatic me-tastases from hepatocellular carcinoma. J Gastroenterol 2004; 39: 961-968.
8. Ho CL, Chen S, Yeung DW, Cheng TK. Dual-Tracer PET/CT Imaging in the Evaluation of Metasttatic Hepatocellular Carcinoma. J Nuclear Med 2007; 48: 902-909.
9. Sharma P, Singh H, Kumar R, Kumar R, Bal C, Malhotra A. Role of 18F-FDG PET-CT for detection of extrahepatic metastasis in patients with hepatocellular carcinoma: Comparison with conventional imaging. J nuclear medicine 2011; 52 Suppl 1: 315.
10. Seo HJ, Choi YJ, Kim HJ, Jeong YH, Cho A, Lee JH, Yun M, Choi HJ, Lee JD, Kang WJ. Evaluation of Bone Metastasis from Hepatocellular Carcinoma Using 18F-FDG PET/CT and 99mTc-HDP Bone Scintigraphy: Characteristics of Soft Tissue Formation. Nucl Med Mol Imaging 2011; 45: 203-211.
11. Lodge MA, Lucas JD, Marsden PK. A PET study of 18F FDG uptake in soft tissue mass. Eur J Nucl Med 1999; 26: 22-30.
12. Lin WY, Tsai SC, Hung GU. Value of delayed 18F-FDG PET imaging in detection of hepato-cellular carcinoma. Nucl Med Commun 2005; 26: 315-321.